1. Home
  2. NXP vs FTRE Comparison

NXP vs FTRE Comparison

Compare NXP & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXP
  • FTRE
  • Stock Information
  • Founded
  • NXP 1992
  • FTRE 1996
  • Country
  • NXP United States
  • FTRE United States
  • Employees
  • NXP N/A
  • FTRE N/A
  • Industry
  • NXP Trusts Except Educational Religious and Charitable
  • FTRE Medical Specialities
  • Sector
  • NXP Finance
  • FTRE Health Care
  • Exchange
  • NXP Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • NXP 741.7M
  • FTRE 864.4M
  • IPO Year
  • NXP N/A
  • FTRE N/A
  • Fundamental
  • Price
  • NXP N/A
  • FTRE $10.13
  • Analyst Decision
  • NXP
  • FTRE Hold
  • Analyst Count
  • NXP 0
  • FTRE 9
  • Target Price
  • NXP N/A
  • FTRE $12.81
  • AVG Volume (30 Days)
  • NXP 70.0K
  • FTRE 1.4M
  • Earning Date
  • NXP 01-01-0001
  • FTRE 11-07-2025
  • Dividend Yield
  • NXP 4.04%
  • FTRE N/A
  • EPS Growth
  • NXP N/A
  • FTRE N/A
  • EPS
  • NXP 0.54
  • FTRE N/A
  • Revenue
  • NXP N/A
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • NXP N/A
  • FTRE N/A
  • Revenue Next Year
  • NXP N/A
  • FTRE N/A
  • P/E Ratio
  • NXP $26.81
  • FTRE N/A
  • Revenue Growth
  • NXP N/A
  • FTRE N/A
  • 52 Week Low
  • NXP $12.91
  • FTRE $3.97
  • 52 Week High
  • NXP $14.89
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • NXP 57.43
  • FTRE 53.94
  • Support Level
  • NXP $14.34
  • FTRE $9.26
  • Resistance Level
  • NXP $14.55
  • FTRE $9.91
  • Average True Range (ATR)
  • NXP 0.13
  • FTRE 0.55
  • MACD
  • NXP -0.02
  • FTRE -0.10
  • Stochastic Oscillator
  • NXP 26.70
  • FTRE 51.40

About NXP Nuveen Select Tax Free Income Portfolio

Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: